These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 868124)

  • 21. [Is drug therapy safer as a result of the drug legislation?].
    Kimbel KH
    Internist (Berl); 1980 Jun; 21(6):306-10. PubMed ID: 7005166
    [No Abstract]   [Full Text] [Related]  

  • 22. [Epidemiological aspects of therapy analyses in clinical and ambulatory patients].
    Stika L; Modr Z
    Z Arztl Fortbild (Jena); 1980 Dec; 74(23):1098-9. PubMed ID: 7010804
    [No Abstract]   [Full Text] [Related]  

  • 23. Prescribing principles for children: foundation of a rational approach.
    Adcock KG
    Adv Nurse Pract; 2006 Mar; 14(3):30-5; quiz 36. PubMed ID: 16548126
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescriptions for Schedule II controlled substances: Drug Enforcement Administration, Justice. Notice of proposed rulemaking.
    Fed Regist; 1980 Apr; 45(70):24199-200. PubMed ID: 10246081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The doctor's responsibility and risk in the prescribing of drugs].
    Aschenbrenner R
    Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431
    [No Abstract]   [Full Text] [Related]  

  • 26. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of pharmacotherapy in general-internal ambulatory care as a possibility of quality control].
    Zschokke U; Conen D; Dubach UC
    Schweiz Med Wochenschr; 1981 Jan; 111(1):14-20. PubMed ID: 7209475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Does budgeting modify quality and efficiency of ambulatory drug therapy? Use of indicators exemplified by the prescribing behavior of established physicians of a North German region with predetermined quality deficits before introduction of the Health Structural Law].
    Vitt KD; Buss G; Erben CM; Schönhöfer PS
    Gesundheitswesen; 1995 Mar; 57(3):171-6. PubMed ID: 7756769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prescription of drug distribution from pharmacies by labels].
    Kashpers'ka VM
    Farm Zh; 1978; (6):72-5. PubMed ID: 729767
    [No Abstract]   [Full Text] [Related]  

  • 30. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemiological data on drug use during pregnancy in Thuringia, East Germany, 1993.
    Reimann IR; Karpinsky C; Hoffmann A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):80-3. PubMed ID: 8929751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of medication profiles to detect potential therapeutic problems in ambulatory patients.
    Solomon DK; Baumgartner RP; Glascock LM; Glascock SA; Briscoe ME; Billups NF
    Am J Hosp Pharm; 1974 Apr; 31(4):348-54. PubMed ID: 4822024
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current problems of pharmacotherapy. 8. Stationary and ambulatory treatment with drugs. 1].
    Oehme P; Brüschke G; Herling M
    Dtsch Gesundheitsw; 1970 May; 25(20):909-11. PubMed ID: 5535556
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the work of the committees for scientific prescriptions].
    Michael R
    Pharm Prax; 1966; 2():35-40. PubMed ID: 5914263
    [No Abstract]   [Full Text] [Related]  

  • 35. [Position of neuropsychiatry in ambulatory health care].
    Müller K
    Z Arztl Fortbild (Jena); 1973 Apr; 67(8):399-401. PubMed ID: 4731515
    [No Abstract]   [Full Text] [Related]  

  • 36. [Observance of expert testimonies by the Drug Commission in health-insurance prescriptions].
    Rieger HJ
    Dtsch Med Wochenschr; 1974 Oct; 99(42):2126-8. PubMed ID: 4426234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug therapy between possibility and necessity].
    Ankermann H; Hüller H; Jung F
    Z Arztl Fortbild (Jena); 1983; 77(13):541-5. PubMed ID: 6624154
    [No Abstract]   [Full Text] [Related]  

  • 39. Problems with medicines.
    Caranasos GJ
    Prim Care; 1980 Dec; 7(4):575-84. PubMed ID: 6908082
    [No Abstract]   [Full Text] [Related]  

  • 40. [Scientific bases for the effective use of drugs in medical care based on an analysis of drug utilization. Goal and content of utilization analysis. Use of analysis results in the collaboration of pharmaceutical and medical care areas].
    Görlt H; Lohmann D
    Z Arztl Fortbild (Jena); 1984; 78(16):661-6. PubMed ID: 6495784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.